Upgrade to SI Premium - Free Trial

Roadzen Delivers Best Quarter in Company History with Q4 FY2026 Revenue of $16.1 Million, Up 42% Year-Over-Year; Record Full-Year Revenue of $55.0 Million, Up 24%

June 29, 2026 8:00 AM

Roadzen Posts First ‘Rule of 40’ Quarter in Two Years; FY2026 Net Loss Narrows 69% and Adjusted EBITDA Loss Improves 58%, with Seventh Straight Quarter of Adjusted EBITDA Gains Nearing Breakeven

_______________________
1 Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.

NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the Fiscal 2026 fourth quarter and full year ended March 31, 2026.

Commenting on the Company's results, Rohan Malhotra, Founder and CEO of Roadzen, stated, "This was the best quarter in our history. We have been building towards this growth for two years by laying the groundwork — we are seeing increased adoption of our platform, largely driven by the U.S. and India, and democratic growth across all of our product lines. More customers are adopting more of our platform, across more geographies, and at increasing speed.

We are showcasing real-world AI at scale. Unlike general intelligence models, which are large, expensive and general-purpose, our focus is on building specialized models that deliver enterprise intelligence within context — that are built for precision and the lowest cost of delivery, so that our accuracy translates directly into real economic impact for our customers. As adoption grows, the network effects across our data, distribution, and decisioning compound.

Our goal for this year is clear: to be one of a handful of AI companies, globally, with over $100 million in annual recurring revenue with adjusted EBITDA profitability, and growing more than 40-50% a year. We are still early, but the direction is clear, and we have entered Fiscal 2027 with more momentum, more visibility, and greater conviction than ever before."

Roadzen's CFO, Jean-Noël Gallardo, commented, "The Fiscal fourth quarter represented a clear acceleration in Roadzen's financial trajectory, with record quarterly revenue growing 42% year-over-year and 12% sequentially, driving meaningful operating leverage and continued improvement in our financial metrics. While our net loss for the quarter was $(7.3) million, or $(0.09) per share, we reduced our full-year Fiscal 2026 net loss by approximately 69% over the prior year. Our Adjusted EBITDA loss narrowed to $(0.4) million — our seventh consecutive quarter of improvement — bringing the Company closer to Adjusted EBITDA breakeven. We are also exceptionally pleased to report our first ‘Rule of 40’ quarter since the U.K. pause. The growth we are seeing in our acquired businesses is being driven by the synergies we have created across the Roadzen platform — by connecting them to our AI, our distribution, and our customer base, we are accelerating their growth well beyond what they could achieve independently.

There is clear momentum in the operating performance of the business, where year-over-year revenue growth has accelerated from an average of 18% in the first half of this year to more than 30% growth in the second half, while our Adjusted EBITDA margin narrowed from -10.2% to -3.3% over the same period — showing both sustained commercial acceleration and a clear trend toward breakeven.

We also made decisive improvements to our balance sheet. We reduced short-term borrowings by approximately 60%, from $19.9 million to $7.8 million, while extending into longer-duration debt — including the extension of our $11.5 million senior secured facility with Mizuho to July 2027 — strengthening our near-term liquidity position and capital flexibility. We raised capital almost entirely through clean equity, largely at a premium to our market price, including at the India subsidiary level. The balance sheet clean-up remains a focus for us as we continue to strengthen the foundations of the business."

Fourth Quarter and Full Year Financial Highlights

P&L

Revenue and Key Performance Indicators:

Net Results:

Balance Sheet

Assets:

Liabilities:

Capitalization:

drivebuddyAI Developments:

Acquisitions: Strategic Acquisitions Unlock New Markets and Full-Stack Control

FY2027 – Off to a Strong Start with Over $30 Million in New Annual Revenue Mandates

Financial Developments

Revenue & Commercial Deployments:

Strategic Partnerships & Ecosystem Expansion:

Other Interest:

For more information about Roadzen Inc., please visit https://roadzen.ai.

About Roadzen Inc. Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences. Thousands of clients across North America, Europe, and Asia — from the world's leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. Roadzen's pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world's top AI innovators. Headquartered in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India, and China. Learn more at www.roadzen.ai.

Cautionary Statement Regarding Forward Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," and "continue," or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, our expected revenue growth and anticipated Adjusted EBITDA breakeven timing, expected revenue and results from announced contracts and strategic partnerships, the anticipated synergies and growth from our acquisitions, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in "Risk Factors" in our Securities and Exchange Commission ("SEC") filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact: Investor Contacts: [email protected] Media Contacts: Sanya Soni [email protected] or [email protected]

Financial Statements Follow

Roadzen Inc.
Consolidated Balance Sheets
(in US $, except share count)
Particulars
As of
March 31, 2026
As of
March 31, 2025
Assets
Current assets:
Cash and cash equivalents6,578,594 4,836,576
Accounts receivable, net7,500,439 2,625,385
Inventories116,555 202,535
Prepayments and other current assets17,833,119 19,092,595
Investments229,994 197,805
Total current assets32,258,701 26,954,896
Non current assets
Restricted cash222,026 217,064
Non marketable securities- 269,470
Property and equipment, net536,997 602,923
Goodwill7,616,973 2,061,553
Operating lease right-of-use assets1,374,147 1,109,219
Intangible assets, net9,651,915 1,243,253
Other long-term assets997,802 120,972
Total Non current assets20,399,860 5,624,454
Total assets52,658,561 32,579,350
Liabilities and shareholders' Equity/(Deficit)
Current liabilities
Current portion of long-term borrowings9,829,713 2,904,444
Short-term borrowings7,843,267 19,865,645
Accounts payable and accrued expenses30,245,947 30,254,010
Derivative warrant liabilities1,987,003 1,489,818
Short-term operating lease liabilities325,255 318,921
Other current liabilities8,072,789 2,102,466
Total current liabilities58,303,974 56,935,304
Non current liabilities
Long-term borrowings15,612,108 139,775
Long-term operating lease liabilities699,817 628,400
Other long-term liabilities4,561,246 566,651
Total Non current liabilities20,873,171 1,334,826
Total liabilities79,177,145 58,270,130
Commitments and contingencies (refer note 22)
Shareholders' Equity/(Deficit)
Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of March 31, 2026 and March 31, 2025; 79,695,672 and 74,290,986 shares outstanding as of March 31, 2026 and March 31, 2025 respectively112,128,293 95,501,291
Accumulated deficit(246,224,660)(223,826,442)
Accumulated other comprehensive income/(loss)(1,299,868)(468,859)
Other components of equity105,747,998 103,720,113
Total shareholders’ deficit(29,648,237)(25,073,897)
Non-controlling interest3,129,653 (616,883)
Total deficit(26,518,584)(25,690,780)
Total liabilities and Total Deficit52,658,561 32,579,350
The accompanying notes are an integral part of these consolidated financial statements.


Roadzen Inc.
Consolidated Statements of Operations
(in US $, except share count)
ParticularsFor the three months ended
March 31,
For the year ended
March 31,
2026
2025
2026
2025
Revenue16,121,304 11,330,827 55,021,792 44,296,098
Costs and expenses:
Cost of services5,537,522 3,893,120 21,277,579 18,833,218
Research and development(115,664)244,928 408,355 3,779,955
Sales and marketing9,349,677 7,133,481 29,111,662 28,873,150
General and administrative6,069,343 2,694,733 15,976,982 51,602,107
Depreciation and amortization1,057,462 1,046,539 2,244,268 2,020,610
Total costs and expenses21,898,341 15,012,801 69,018,846 105,109,040
Loss from operations(5,777,037)(3,681,974)(13,997,054)(60,812,942)
Interest expense (net)(1,871,764)(714,899)(7,249,803)(3,247,831)
Gain on bargain purchase174,248 174,248
Fair value gains/(losses) in financial instruments carried at fair value635,187 1,681,725 (3,984,386)(14,844,420)
Impairment of investment(269,470)(1,245,326)(269,470)(1,245,326)
Other income (net)(193,775)3,861,541 2,329,515 7,073,235
Total other income/(expense)(1,525,574)3,583,041 (8,999,896)(12,264,342)
Loss before income taxes and equity-method investment activity(7,302,611)(98,933)(22,996,950)(73,077,284)
Equity method investment activity, net
(Loss)/Income before income tax expense(7,302,611)(98,933)(22,996,950)(73,077,284)
Less: income tax (benefit)/expense(46,966)69,709 20,212 (13,973)
Net (loss)/income before non-controlling interest(7,255,645)(168,642)(23,017,162)(73,063,311)
Net loss attributable to non-controlling interest, net of tax(1,733)(61,675)(500,940)(192,879)
Net Loss attributable to Ordinary shareholders(7,253,912)(106,967)(22,516,222)(72,870,432)
Net loss per share attributable to Ordinary shareholders
Basic and diluted(0.09)(0.00)(0.29)(1.04)
Weighted-average number of shares used in computing net loss per share79,673,597 68,882,560 77,454,509 69,867,792
The accompanying notes are an integral part of these consolidated financial statements.


RoadzenInc.
Unaudited Condensed Consolidated Statements of Cash Flow
(in US $, except share count)
ParticularsFor the year ended
March 31,
2026
2025
Cash flows from operating activities
Net Loss attributable to Ordinary shareholders(22,516,222)(72,870,432)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization2,244,268 2,020,610
Stock based compensation497,806 47,211,816
Deferred income taxes(14,303)(193,261)
Unrealised foreign exchange loss/(profit)(831,009)132,121
Gain over liability settled /expenses settled through issuance of equity equity shares(64,875)-
Fair value losses/(profits) in financial instruments carried at fair value3,984,386 14,844,420
Impairment of investment269,470 1,245,326
Expected credit loss (net of reversal)2,654,182 246,115
Assets written off82,032 -
Balances written off/(back)(1,545,749)(8,143,051)
Gain on extinguishment of intercompany financial assets and liabilities(482,689)-
Net total loss attributable to non-controlling interest, net of tax(500,940)(192,879)
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:
Inventories85,980 (131,868)
Accounts receivables, net(4,776,282)780,880
Prepayments and other assets(3,159,457)(4,822,952)
Accounts payable and accrued expenses225,170 2,833,077
Other liabilities3,576,831 (1,102,120)
Net cash used in operating activities(20,271,401)(18,142,198)
Cash flows from investing activities
Purchase of property and equipment & intangible assets(1,009,660)(424,910)
Proceeds from sale of mutual fund112,847 309,289
Net cash used in investing activities(896,813)(115,621)
Cash flows from financing activities
Proceeds from issue of ordinary shares6,519,429 7,073,913
Proceeds from issue of equity shares of subsidiary6,645,789 -
Net proceeds/(payments) from borrowings8,279,523 3,669,290
Proceeds from forward purchase agreement- 1,000,000
Net cash generated from financing activities21,444,741 11,743,203
Effect of exchange rate changes on cash and cash equivalents- 3,168
Net (decrease)/increase in cash and cash equivalents (including restricted cash)276,527 (6,511,448)
Cash acquired in business combination1,470,453 -
Cash and cash equivalents at the beginning of the period (including restricted cash)5,053,640 11,565,088
Cash and cash equivalents at the end of the period (including restricted cash)6,800,620 5,053,640
Reconciliation of cash and cash equivalents
Cash and cash equivalents6,578,594 4,836,576
Restricted cash222,026 217,064
Total cash and cash equivalents6,800,620 5,053,640
Supplemental disclosure of cash flow information
Cash paid for interest, net of amounts capitalized2,742,101 1,318,139
Non-cash investing and financing activities
Consideration payable in connection with acquisitions6,407,380 8,376,253
Interest accrued on borrowings3,659,399 2,123,633
The accompanying notes are an integral part of these consolidated financial statements.

Non-GAAP Financial Measures This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (Adjusted EBITDA), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flow provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.

Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.

The following tables reconcile our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:

For the three months ended
March 31,
Change
amount
%
Particulars2026
2025
Net loss(7,253,912)(106,967)(7,146,944)6681%
Adjusted for:
Other (income)/expense net193,775 (3,861,541)4,055,316 -105%
Interest (income)/expense1,871,764 714,899 1,156,865 162%
Gain on bargain purchase(174,248)- (174,248)100%
Fair value changes in financial instruments carried at fair value(1)(635,187)(1,681,725)1,046,538 -62%
Gain on deconsolidation of subsidiaries- - - -
Impairment of goodwill and intangibles with definite life- - - -
Impairment of investment- - - -
Impairment of investment269,470 1,245,326 (975,856)-78%
Tax (benefit)/expense(46,966)69,709 (116,675)-167%
Depreciation and amortization1,057,462 1,046,539 10,923 1%
Stock based compensation expense285,243 76,397 208,846 273%
Non-cash expenses2,556,635 493,210 2,063,425 418%
Non-recurring expenses1,437,515 386,746 1,050,769 272%
Adjusted EBITDA(438,449)(1,617,407)1,178,958 -73%
For the year ended
March 31,
Change
amount
%
Particulars2026
2025
Net loss(22,516,222)(72,870,432)50,354,210 -69%
Adjusted for:- -
Other (income)/expense net(2,329,515)(7,073,235)4,743,720 -67%
Interest (income)/expense7,249,803 3,247,831 4,001,972 123%
Gain on bargain purchase(174,248)- (174,248)100%
Fair value changes in financial instruments carried at fair value(1)3,984,386 14,844,420 (10,860,034)-73%
Gain on deconsolidation of subsidiaries- - - 100%
Impairment of goodwill and intangibles with definite life- - - -
Impairment of investment- - - -
Impairment of investment269,470 1,245,326 (975,856)-78%
Tax (benefit)/expense20,212 (13,973)34,185 -245%
Depreciation and amortization2,244,268 2,020,610 223,658 11%
Stock based compensation expense497,806 47,211,816 (46,714,010)-99%
Non-cash expenses2,990,808 1,649,448 1,341,360 81%
Non-recurring expenses4,252,368 1,340,062 2,912,306 217%
Adjusted EBITDA(3,510,864)(8,398,127)4,887,263 -58%

(1) Fair value changes in financial instruments are considered to be financing costs as they relate to convertible notes and the Forward Purchase Agreement. These changes are non-cash as these changes in fair value are affected by the volatility of the Company's share price.


Categories

Globe Newswire Press Releases